CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Tedizolid phosphate

Last Updated: January 16, 2015
Result type: Reports
Project Number: SR0413-000
Product Line: Reimbursement Review

Generic Name: Tedizolid phosphate

Brand Name: Sivextro

Manufacturer: Cubist Pharmaceuticals Canada, Inc.

Indications: Acute bacterial skin and skin structure infections

Submission Type: Pre-NOC

Project Status: Withdrawn